Silverback Therapeutics Inc and ARS Pharmaceuticals Inc Merger Announcement Call Transcript
Good afternoon, everyone, and thank you for joining us today. (Operator Instructions) As a reminder, this conference call is being recorded.
I would now like to turn the call over to Miguel Arcinas, Vice President, Corporate Development and Investor Relations of the Silverback Therapeutics.
Thank you and good afternoon. Joining me on today's call from the Silverback team are Laura Shawver, Chief Executive Officer; Valerie Odegard, President and Chief Scientific Officer; and Jonathan Piazza, Chief Financial Officer. From the ARS Pharma team, we have Richard Lowenthal, Chief Executive Officer; Sarina Tanimoto, Chief Medical Officer; Eric Karas, Chief Commercial Officer; Kathy Scott, Chief Financial Officer; and Justin Chakma, Chief Business Officer.
The recording and the slides presented during this call will be available on the Investor Relations section of Silverback's website and the news section of ARS's website for 30 days.
Before I start, I would
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
